))
Improving Diversity in Clinical Trials
Manage episode 352868196 series 3397370
Content provided by Jesse Goodwin, PhD and Jesse Goodwin. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jesse Goodwin, PhD and Jesse Goodwin or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Joining Jesse and Kevin in the MUSC podcast studio is, Marvella Ford, Ph.D., the Associate Director of Population Sciences and Cancer Disparities at the Hollings Cancer Center at MUSC.
Dr. Ford’s research into health disparities highlights the importance of including diverse populations in cancer research and the impact of lifestyle on breast cancer risk. Listen in as she outlines how far we’ve come in minority health screenings, confronting the atrocities of the Tuskegee study and going with an earnest heart into communities to improve participation in clinical trials.
00:00 The Start
01:53 Dr. Ford joins the show
04:20 Addressing major gaps in cancer death rates between populations
07:03 Personal stories from local town halls and community members
12:39 Importance of getting specialized populations into more diverse clinical trials
16:12 Discussion of the Tuskegee Study and better protection of trial participants
24:31 The future of community partnerships in clinical trials
Learn more about innovation at the Medical University of South Carolina (MUSC) by visiting: https://web.musc.edu/innovation
22 episodes
Share
